BILLERICA, Mass.--(BUSINESS WIRE)--
Insulet Corporation (NASDAQ: PODD) (Insulet or the Company), the leader
insulin pump technology with its Omnipod® Insulin
Management System, today announced that management will present at two
upcoming investor conferences:
The Cowen and Company 37th Annual Health Care Conference in Boston,
Massachusetts on Monday, March 6, 2017 at 2:00pm (Eastern Time).
The Raymond James 38th Annual Institutional Investors Conference in
Orlando, Florida on Tuesday, March 7, 2017 at 11:35am (Eastern Time).
To listen to live audio webcasts of the presentations, please visit http://investors.insulet.com/.
Replays of the webcasts will also be available following the events.
About Insulet Corporation:
Insulet Corporation (NASDAQ: PODD) is an innovative medical device
company dedicated to making the lives of people with diabetes easier.
Through its Omnipod Insulin Management System, Insulet seeks to expand
the use of insulin pump therapy among people with insulin-dependent
diabetes. The Omnipod is a revolutionary and easy-to-use tubeless
insulin pump that features just two parts and a fully-automated cannula
insertion. Insulet's Delivery Systems business also partners with global
pharmaceutical and biotechnology companies to tailor the Omnipod
technology platform for the delivery of subcutaneous drugs across
multiple therapeutic areas. Founded in 2000, Insulet Corporation is
based in Billerica, Massachusetts. For more information, please visit: http://www.myomnipod.com.
View source version on businesswire.com: http://www.businesswire.com/news/home/20170213005125/en/
Deborah R. Gordon, 978-600-7717
President, Investor Relations and Corporate Communications
Source: Insulet Corporation
News Provided by Acquire Media